TrialWire delivers rapid patient recruitment for tough to recruit clinical trials. TrialWire is the leading patient recruitment agency in Asia, Australia and New Zealand with more than 15 years of clinical trial patient recruitment success. The agency uses modern and trusted media communications solutions so more people find out about clinical trials that might be right for them.

 

irish-handsOUR MISSION

TrialWire is for CROs, Sponsors and Sites who need to rapidly boost patient recruitment.

The agency delivers proven ways to use the power of news media and modern communication tools to engage and convert target patient audiences.

TrialWire gets your clinical trial in the media that target patients trust for their health information.

At the core of all our work is measurement and daily or weekly analytics reporting.

What is TrialWire?

The team uses the latest communications channels including Facebook, Twitter and Instagram, health blogs and traditional health and lifestyle media to reach the right people - in the right locations - to inform them about clinical trials that might be right for them.

TrialWire offers 5 key media products that are designed to either work independently or integrate to form a powerful recruitment solution.

NewsAlert

NewsAlert is "earned news media", or put simply articles and news reports prepared by respected journalists and bloggers - not paid advertising.

The NewsAlert "earned news media" solution has been delivering for more than 15 years, successfully boosting patient recruitment for clinical trials to meet recruitment timelines.

Some people call it PR or public relations, but it's all about delivering "earned media" - the most trusted and credible news media that's created by real journalists and leading health bloggers.

NewsAlert gets your Study news and contact details in front of your ideal patient via the news media they trust. Click here to try now

Newscaster

Newscaster is a smart press release service that sits out on the internet to be found by anyone searching the Study TA. Interested people read about the Study and, if they might be eligible, they are directed to their nearest Clinic.

Newscaster includes a press release writing service, any edits through the IRB/EC approval process, and hosting and sharing among TA target audiences online as well as engaging patient advocacy groups to share the Newscaster with their members and on their websites.Click here to try now

Mediscreener

Mediscreener is a modern sophisticated online eligibility screener that surveys patients then directs those eligible to their nearest Clinics. Unlike most screeners, Mediscreener can be ready in under 24 hours and typically is approved by IRB/EC in record time because it doesn't collect patient data so there are no privacy or data concerns. Medicsreener is a one-off fee and just $299 per month for unlimited patients and Clinics. Click here to try now

Unlike most screeners, Mediscreener can be ready in under 24 hours and typically is approved by IRB/EC in record time because it doesn't collect patient data - so there are no privacy or data concerns. Medicsreener is a one-off fee and just $299 per month for unlimited patients and Clinics. Click here to try now

Medicsreener is a one-off fee and just $299 per month for unlimited patients and Clinics. Click here to try now

Social Media Study Post Campaigns

We have more than a decade of experience in delivering powerful social media Study Posts that

  • recruit the right patients
  • include targeting people who live near Clinics and who have the right health and demographic profiles

Study Posts simply requires IRB/EC approval of a Study Post (which we produce).Click here to try now

Patient advocacy groups and organisations

We work closely with all the TA patient advocacy groups to share Study information with their members.

We prepare submissions for their boards and provide all the data needed to get a Study shared on their websites and via their member databases. Click here to try now

These TrialWire products get your Study featured in the media that your target patients trust for health information.